CGM Academy: virtual education for kids and teens with type 1 diabetes
Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes
This trial tests whether a virtual education program helps children and teens (ages 8–18) with type 1 diabetes using Dexcom CGM reduce glucose swings compared with standard education.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 8 Years to 18 Years |
| Sex | All |
| Sponsor | Children's Hospital Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06408207 on ClinicalTrials.gov |
What this trial studies
This is a randomized trial comparing a structured virtual education curriculum (interactive workbook, video links, and four online group sessions with diabetes education specialists) to standard education for youth with type 1 diabetes who use Dexcom G6/G7 continuous glucose monitors. The primary outcome is change in glucose variability measured by CGM data, with questionnaires on diabetes distress, family responsibilities, and hours of diabetes education collected at enrollment, week 4, and 6 months. Eligible participants are 8–18 years old with T1D duration of at least 6 months, English or Spanish speakers, and have a smartphone compatible with Dexcom G6/G7. The study is run through Children's Hospital Los Angeles and delivered virtually to enrolled participants.
Who should consider this trial
Good fit: Children and adolescents aged 8–18 with type 1 diabetes for at least 6 months who can use a Dexcom G6/G7-compatible smartphone, speak English or Spanish, and participate in virtual sessions are ideal candidates.
Not a fit: Patients with known medical adhesive allergies, those without a compatible smartphone or unable to join virtual visits, or those in the early honeymoon phase of diabetes may not benefit from or be eligible for this program.
Why it matters
Potential benefit: If successful, the program could help youth using CGM reduce glucose variability and improve day-to-day glucose management.
How similar studies have performed: Previous research shows CGM and structured diabetes education can improve glycemic outcomes in youth, but this specific virtual, group-based CGM education curriculum is a relatively novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7 * T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D * Able to speak, read, and write English or Spanish * Smartphone compatible with Dexcom G6 and G7application * Ability to participate in virtual visits Exclusion Criteria: • Known history of medical adhesive allergies
Where this trial is running
Los Angeles, California
- Children's Hospital Los Angeles — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Rebecca Barber, PhD, RN — Children's Hospital Los Angeles
- Study coordinator: Rebecca Barber, PhD, RN
- Email: rbarber@chla.usc.edu
- Phone: (323) 361-1359
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.